Kennedy Capital Management, Inc. Ionis Pharmaceuticals Inc Transaction History

Kennedy Capital Management, Inc.

$4.27 Billion
Q3 2024

A detailed history of Kennedy Capital Management, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 162,076 shares of IONS stock, worth $6.11 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

162,076

Previous 254,343 36.28%

Holding current value

$6.11 Million

Previous $12.1 Million 46.44%

% of portfolio

0.15%

Previous 0.28%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.06 - $51.86 $3.7 Million - $4.78 Million	-92,267 Reduced 36.28%	162,076 $6.49 Million
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $175,543 - $229,723	4,816 Added 1.93%	254,343 $12.1 Million
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $886,917 - $1.13 Million	21,102 Added 9.24%	249,527 $10.8 Million
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $443,011 - $527,142	-10,210 Reduced 4.28%	228,425 $11.6 Million
Q3 2023 Nov 14, 2023	BUY	$38.5 - $47.13 $322,399 - $394,666	8,374 Added 3.64%	238,635 $10.8 Million
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $1.66 Million - $2.07 Million	47,836 Added 26.22%	230,261 $9.45 Million
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $1.45 Million - $1.78 Million	43,244 Added 31.07%	182,425 $6.52 Million
Q4 2022 Feb 14, 2023	SELL	$37.12 - $46.52 $208,391 - $261,163	-5,614 Reduced 3.88%	139,181 $5.26 Million
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $917,629 - $1.22 Million	25,113 Added 20.98%	144,795 $6.4 Million
Q2 2022 Aug 10, 2022	BUY	$31.71 - $43.0 $3.48 Million - $4.72 Million	109,834 Added 1115.29%	119,682 $4.43 Million
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $69,172 - $85,747	2,315 Added 30.73%	9,848 $365,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $13,598 - $18,638	-531 Reduced 6.58%	7,533 $229,000
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $8,888 - $10,745	-265 Reduced 3.18%	8,064 $270,000
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $11,087 - $15,167	321 Added 4.01%	8,329 $332,000
Q1 2021 May 14, 2021	BUY	$42.51 - $63.78 $76,390 - $114,612	1,797 Added 28.93%	8,008 $360,000
Q4 2020 Feb 12, 2021	BUY	$45.3 - $60.27 $281,358 - $374,336	6,211 New	6,211 $351,000

Others Institutions Holding IONS

# of Institutions

403

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.

Account

Kennedy Capital Management, Inc. Ionis Pharmaceuticals Inc Transaction History